When was Crystal Pharmatech founded?

Crystal Pharmatech was founded in 2010 and raised its 1st funding round 5 years after it was founded.

Where is Crystal Pharmatech located?

Crystal Pharmatech is headquartered in Suzhou, China.

How many employees does Crystal Pharmatech have?

As of Dec 31, 2024, the latest employee count at Crystal Pharmatech is 30.

Is Crystal Pharmatech a funded company?

Crystal Pharmatech is a funded company, having raised a total of $24.5M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 15, 2015.

When was the latest funding round of Crystal Pharmatech?

Crystal Pharmatech's latest funding was a $***** Series B round on Dec 25, 2018, with participation from 2 investors. Its primary sector is Biopharma Outsourcing. In China, the Biopharma Outsourcing sector has seen $50.6M in funding in 2026 to date.

Where does Crystal Pharmatech rank among its competitors?

Crystal Pharmatech ranks 8th amongst 387 active competitors, of which 36 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Tenpoint Therapeutics, which secured $85M in Jan, 2026.

Who are the top competitors of Crystal Pharmatech?

Crystal Pharmatech's top competitors include LabCorp, Charles River Laboratories and Cytel. Among them, Tenpoint Therapeutics secured the most recent funding round in January, 2026.

Crystal Pharmatech - 2026 Company Profile, Team, Funding & Competitors

Crystal Pharmatech is a series B company based in Suzhou (China), founded in 2010 by Alex Chen. It operates as a Provider of solid state research services for small molecules. Crystal Pharmatech has raised $24.5M in funding from investors like Renren, Cowin Capital and Shiyu. The company has 387 active competitors, including 36 funded and 59 that have exited. Its top competitors include companies like LabCorp, Charles River Laboratories and Cytel.

Company Details

Crystal Pharmatech is a technology-driven CRO which focuses on the specialized field of materials science and its applications w.r.t drug development. It helps its clients in discovering and selecting the optimal solid phase for development. It also supports all solid-state aspects of formulation studies, API process development, formulation development, regulatory, and intellectual property protection. The company offers a full range of services right from being the solid-state support arm to its clients and offering consulting services on specific issues.

Website: www.crystalpharmatech.com/
Social

Key Metrics

Founded Year

2010

Location

Suzhou, China

Stage

Series B

Total Funding

$24.5M in 2 rounds

Latest Funding Round

Series B, Dec 25, 2018, $*****

Investors

Renren & 2 more

Ranked

8^th among 387 active competitors

Employee Count

30 as on Dec 31, 2024

Similar Companies

LabCorp & 431 more

View Crystal Pharmatech's full profile

Crystal Pharmatech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Crystal Pharmatech Inc CIN: 273871419 , United States, Active	Dec 31, 1999	-	30 (As on Dec 31, 2024)	-

Crystal Pharmatech has raised a total funding of $24.5M over 2 rounds. Its first funding round was on Sep 15, 2015. Its latest funding round was a Series B round on Dec 25, 2018 for $*****. 2 investors participated in its latest round. Crystal Pharmatech has 3 institutional investors.

Here is the list of recent funding rounds of Crystal Pharmatech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 25, 2018	7387653	Series B	2910838	8471575	9275216	3299866
Sep 15, 2015	4319849	Series A	9542922	5465428	Renren	5370913

Access funding benchmarks and valuations. Sign up today!

View details of Crystal Pharmatech's funding rounds and investors

The founders of Crystal Pharmatech is Alex Chen.

Here are the details of Crystal Pharmatech's key team members:

Alex Chen: Co-Founder, Chief Executive Officer of Crystal Pharmatech.

View details of Crystal Pharmatech's Founder profiles and Board Members

Crystal Pharmatech's employee count trend

Crystal Pharmatech has 30 employees as of Dec 24. Here is Crystal Pharmatech's employee count trend over the years:

Employee count trend for Crystal Pharmatech

Uncover Crystal Pharmatech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Crystal Pharmatech include LabCorp, Charles River Laboratories and Cytel. Here is the list of Top 10 competitors of Crystal Pharmatech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	LabCorp 1969, Burlington (United States), Public	Provider of laboratory tests for physicians	-	The MassMutual Trust Company, F.S.B., JANA Partners ... & 2 others	76/100
2nd	Charles River Laboratories 1947, Wilmington (United States), Public	Provider of drug discovery and preclinical development services	-	Foundation for Chemistry Research & Initiatives, Interactive Advisors ... & 7 others	66/100
3rd	Cytel 1987, Cambridge (United States), Acquired	Provider of data analysis and statistical solutions for the life sciences industry	$2M	Autonomy Ventures, Merck & 3 others	65/100
4th	Precision for Medicine 2013, United States, Late Stage	Provider of clinical research services, laboratory services, and data intelligence	$150M	Oak Investment Partners, J.H. Whitney Capital Partners ... & 1 others	63/100
5th	Veeda Lifesciences 2004, Ahmedabad (India), Series B	Provider of clinical research services for drug development and testing	$83.3M	Actis, ValueQuest & 50 others	62/100
6th	Tenpoint Therapeutics 2020, Seattle (United States), Series B	Developer of engineered cell-based therapeutics to restore vision	$155M	EQT, Janus Henderson Investors & 20 others	60/100
7th	Frontage Laboratories 2001, Exton (United States), Public	Global pharmaceutical development organization providing comprehensive drug discovery and development services	$10.2M	Baird Capital, TF Capital	57/100
8th	Crystal Pharmatech 2010, Suzhou (China), Series B	Provider of solid state research services for small molecules	$24.5M	Cowin Capital, Renren & 1 others	57/100
9th	Presidio Medical 2017, Reno (United States), Series C	Bioelectronic medicine company developing a fundamental neuromodulation platform	$102M	Deerfield, Invus & 3 others	55/100
10th	Medimaps Group 2006, Geneva (Switzerland), Series B	Developer of AI-powered bone health assessment software	$20M	Swisscanto, Verve Ventures & 2 others	54/100